[G21-03] Ivacaftor (cystic fibrosis) - Addendum to Commissions G20-18, G20-20, A20-77, A20-83
Last updated 18.02.2021
Commission awarded on 12.01.2021 by the Federal Joint Committee (G-BA).
Airways and respiratory system
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.